Life science investor Novo Holdings, the venture capital arm of Novo Nordisk Foundation, is expanding into Asia and setting up an office in Singapore, the company said in a statement Thursday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
